Reports for TAKEDA CANADA INC
Company Name
TAKEDA CANADA INC
Totals |
||
Shortage reports |
53 |
|
Actual shortage: | 0 (0%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 53 (100%) | |
Discontinuation Reports |
10 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 10 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
GAMMAGARD LIQUID | 10% | SOLUTION | Resolved | 2019-07-31 | 2020-02-06 | 90434 |
GAMMAGARD S/D | 5G | KIT SOLUTION POWDER FOR SOLUTION | Resolved | 2023-08-23 | 2023-09-14 | 202833 |
GAMMAGARD S/D | 5G | KIT SOLUTION POWDER FOR SOLUTION | Resolved | 2023-10-18 | 2024-01-31 | 207306 |
INTUNIV XR | 4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-08-13 | 2019-09-27 | 91467 |
MEZAVANT | 1.2G | TABLET (DELAYED AND EXTENDED RELEASE) | Resolved | 2020-01-15 | 2020-08-22 | 103353 |
MEZAVANT | 1.2G | TABLET (DELAYED AND EXTENDED RELEASE) | Resolved | 2022-07-18 | 2022-08-19 | 164835 |
MEZAVANT | 1.2G | TABLET (DELAYED AND EXTENDED RELEASE) | Resolved | 2022-10-14 | 2022-11-02 | 171844 |
OBIZUR | 500UNIT | POWDER FOR SOLUTION | Resolved | 2020-07-30 | 2020-08-18 | 121439 |
ONDISSOLVE ODF | 4MG | FILM, SOLUBLE | Resolved | 2017-04-05 | 2017-05-11 | 5605 |
ONDISSOLVE ODF | 8MG | FILM, SOLUBLE | Resolved | 2019-06-20 | 2019-08-07 | 87159 |
RIXUBIS | 1000UNIT | POWDER FOR SOLUTION KIT | Resolved | 2021-07-07 | 2021-08-26 | 141947 |
RIXUBIS | 1000UNIT | POWDER FOR SOLUTION KIT | Resolved | 2023-07-13 | 2023-08-28 | 198631 |
RIXUBIS | 2000UNIT | POWDER FOR SOLUTION KIT | Resolved | 2023-07-13 | 2023-08-28 | 198627 |
RIXUBIS | 3000UNIT | POWDER FOR SOLUTION KIT | Resolved | 2023-07-13 | 2023-08-28 | 198634 |
TAKHZYRO | 300MG | SOLUTION | Resolved | 2021-12-15 | 2022-01-13 | 151175 |
TECTA | 40MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-31 | 2018-09-21 | 57003 |
TECTA | 40MG | TABLET (ENTERIC-COATED) | Resolved | 2019-02-21 | 2019-06-11 | 76478 |
TECTA | 40MG | TABLET (ENTERIC-COATED) | Resolved | 2020-11-16 | 2021-01-22 | 128447 |
VYVANSE | 30MG | CAPSULE | Resolved | 2021-12-02 | 2021-12-12 | 150417 |
VYVANSE | 30MG | CAPSULE | Resolved | 2022-12-19 | 2023-01-16 | 178913 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACTOS | 15MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44428 |
ACTOS | 30MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44433 |
ACTOS | 45MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44438 |
AGRYLIN | 0.5MG | CAPSULE | Discontinued | 2023-11-14 | 2024-03-01 | 210182 |
FOSRENOL | 250MG | TABLET (CHEWABLE) | Discontinued | 2022-12-19 | 2023-04-30 | 178916 |
FOSRENOL | 500MG | TABLET (CHEWABLE) | Discontinued | 2024-05-16 | 2024-06-10 | 228178 |
FOSRENOL | 750MG | TABLET (CHEWABLE) | Discontinued | 2024-05-16 | 2024-08-01 | 228181 |
FOSRENOL | 1000MG | TABLET (CHEWABLE) | Discontinued | 2024-05-16 | 2024-08-01 | 228184 |
PANTO IV | 40MG | POWDER FOR SOLUTION | Discontinued | 2017-03-15 | 2017-03-15 | 2969 |
ULORIC | 80MG | TABLET | Discontinued | 2021-08-17 | 2022-01-04 | 144266 |
Showing 1 to 10 of 10